Denise E. Chou

1.0k total citations
28 papers, 713 citations indexed

About

Denise E. Chou is a scholar working on Psychiatry and Mental health, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Denise E. Chou has authored 28 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 12 papers in Physiology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Denise E. Chou's work include Migraine and Headache Studies (23 papers), Sympathectomy and Hyperhidrosis Treatments (9 papers) and Trigeminal Neuralgia and Treatments (9 papers). Denise E. Chou is often cited by papers focused on Migraine and Headache Studies (23 papers), Sympathectomy and Hyperhidrosis Treatments (9 papers) and Trigeminal Neuralgia and Treatments (9 papers). Denise E. Chou collaborates with scholars based in United States, Switzerland and Germany. Denise E. Chou's co-authors include Peter J. Goadsby, Farooq Maniyar, Till Sprenger, Michael Eller, Christoph J. Schankin, Jean Schoenen, Deena E. Kuruvilla, Vernon Rowe, Paul Schweitzer and Sam Hanon and has published in prestigious journals such as The Journal of Cell Biology, Brain and Neurology.

In The Last Decade

Denise E. Chou

27 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise E. Chou United States 12 461 271 200 135 106 28 713
Nanna Arngrim Denmark 16 426 0.9× 189 0.7× 173 0.9× 93 0.7× 66 0.6× 25 725
G.M. Terwindt Netherlands 10 799 1.7× 329 1.2× 141 0.7× 222 1.6× 48 0.5× 20 956
F. Michael Cutrer United States 14 583 1.3× 286 1.1× 141 0.7× 313 2.3× 32 0.3× 28 804
Yngve Hallström United States 8 807 1.8× 492 1.8× 265 1.3× 70 0.5× 80 0.8× 11 964
Anne Werner Hauge Denmark 11 742 1.6× 385 1.4× 298 1.5× 131 1.0× 36 0.3× 22 861
Lars Lykke Thomsen Denmark 13 717 1.6× 333 1.2× 410 2.0× 124 0.9× 21 0.2× 21 1.0k
Amy R. Tso United Kingdom 10 296 0.6× 171 0.6× 110 0.6× 84 0.6× 51 0.5× 13 470
Kenneth A. Petersen Denmark 16 716 1.6× 411 1.5× 317 1.6× 96 0.7× 18 0.2× 28 1.0k
Irene de Boer Netherlands 13 509 1.1× 230 0.8× 148 0.7× 97 0.7× 32 0.3× 27 637
L. L. Thomsen Denmark 11 713 1.5× 381 1.4× 300 1.5× 151 1.1× 30 0.3× 11 853

Countries citing papers authored by Denise E. Chou

Since Specialization
Citations

This map shows the geographic impact of Denise E. Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise E. Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise E. Chou more than expected).

Fields of papers citing papers by Denise E. Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise E. Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise E. Chou. The network helps show where Denise E. Chou may publish in the future.

Co-authorship network of co-authors of Denise E. Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Denise E. Chou. A scholar is included among the top collaborators of Denise E. Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise E. Chou. Denise E. Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tepper, Stewart J., David W. Dodick, Michel Lantéri‐Minet, et al.. (2024). Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine. JAMA Neurology. 81(11). 1140–1140. 7 indexed citations
3.
Lipton, Richard B., David W. Dodick, David Kudrow, et al.. (2021). Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies. Cephalalgia. 41(14). 1458–1466. 4 indexed citations
4.
Tepper, Stewart J., Messoud Ashina, Uwe Reuter, et al.. (2021). Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials. The Journal of Headache and Pain. 22(1). 81–81. 11 indexed citations
5.
Faust, Elizabeth, Irina Pivneva, Keith A. Betts, et al.. (2021). Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers. Neurology and Therapy. 10(1). 293–306. 22 indexed citations
6.
Schankin, Christoph J., Farooq Maniyar, Denise E. Chou, et al.. (2020). Structural and functional footprint of visual snow syndrome. Brain. 143(4). 1106–1113. 62 indexed citations
7.
Goadsby, Peter J., Uwe Reuter, Yngve Hallström, et al.. (2020). One-year sustained efficacy of erenumab in episodic migraine. Neurology. 95(5). e469–e479. 45 indexed citations
8.
Reuter, Uwe, Todd J. Schwedt, David Kudrow, et al.. (2019). Long-term efficacy of erenumab in patients with episodic migraine who have failed prior preventive migraine therapies. European Journal of Neurology. 26. 637–637. 2 indexed citations
9.
Dodick, David W., Stewart J. Tepper, Hans‐Christoph Diener, et al.. (2019). Efficacy of Erenumab in Chronic Migraine Patients with Medication Overuse and Prior Preventive Treatment Failure (S38.002). Neurology. 92(15_supplement). 2 indexed citations
10.
Chou, Denise E., Peter J. Goadsby, Uwe Reuter, et al.. (2019). Sustained Efficacy Over 1 Year of Treatment With Erenumab: Results From the Extension Phase of the STRIVE Study in Episodic Migraine (S38.005). Neurology. 92(15_supplement). 3 indexed citations
11.
Reuter, Uwe, Todd J. Schwedt, David Kudrow, et al.. (2019). Long-term Efficacy of Erenumab in Patients With Episodic Migraine Who Have Failed Prior Preventive Migraine Therapies (P1.10-020). Neurology. 92(15_supplement). 3 indexed citations
12.
Chou, Denise E., et al.. (2018). Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial. Cephalalgia. 39(1). 3–14. 110 indexed citations
13.
Chou, Denise E., et al.. (2017). External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy. Neuromodulation Technology at the Neural Interface. 20(7). 678–683. 39 indexed citations
14.
Schankin, Christoph J., Farooq Maniyar, Youngho Seo, et al.. (2016). Ictal lack of binding to brain parenchyma suggests integrity of the blood–brain barrier for11C-dihydroergotamine during glyceryl trinitrate-induced migraine. Brain. 139(7). 1994–2001. 62 indexed citations
15.
Chou, Denise E., Amy R. Tso, & Peter J. Goadsby. (2016). Aprepitant for the management of nausea with inpatient IV dihydroergotamine. Neurology. 87(15). 1613–1616. 10 indexed citations
16.
Schankin, Christoph J., Farooq Maniyar, Till Sprenger, et al.. (2015). Brain structural and neurometabolic correlates of visual snow disorder (P1.291). Neurology. 84(14_supplement). 2 indexed citations
17.
Schankin, Christoph J., Farooq Maniyar, Till Sprenger, et al.. (2014). The Relation Between Migraine, Typical Migraine Aura and “Visual Snow”. Headache The Journal of Head and Face Pain. 54(6). 957–966. 125 indexed citations
18.
Maniyar, Farooq, et al.. (2013). Clinical characterization of "visual snow" (Positive Persistent Visual Disturbance). The Journal of Headache and Pain. 14(S1). 4 indexed citations
19.
Donsante, Anthony, et al.. (2011). Increased frequency of congenital heart defects in Menkes disease. Clinical Dysmorphology. 21(2). 59–63. 24 indexed citations
20.
Yang, Felix, Denise E. Chou, Paul Schweitzer, & Sam Hanon. (2010). Warfarin in haemodialysis patients with atrial fibrillation: what benefit?. EP Europace. 12(12). 1666–1672. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nanna Arngrim Breakdown of academic impact, for papers by G.M. Terwindt Breakdown of academic impact, for papers by F. Michael Cutrer Breakdown of academic impact, for papers by Yngve Hallström Breakdown of academic impact, for papers by Anne Werner Hauge Breakdown of academic impact, for papers by Lars Lykke Thomsen Breakdown of academic impact, for papers by Amy R. Tso Breakdown of academic impact, for papers by Kenneth A. Petersen Breakdown of academic impact, for papers by Irene de Boer Breakdown of academic impact, for papers by L. L. Thomsen
Rankless by CCL
2026